Valuation: PT Kalbe Farma Tbk.

Capitalization 55,28500Cr 327.4Cr 280.36Cr 260.72Cr 243.07Cr 454.18Cr 30TCr 487.14Cr 3TCr 1.18TCr 14TCr 1.23TCr 1.2TCr 52TCr P/E ratio 2025 *
16x
P/E ratio 2026 * 14.6x
Enterprise value 5.01TCr 29.68L 25.42L 23.64L 22.04L 41.17L 27Cr 44.16L 2.72Cr 1.07Cr 13Cr 1.11Cr 1.09Cr 47Cr EV / Sales 2025 *
1.44x
EV / Sales 2026 * 1.3x
Free-Float
40.21%
Yield 2025 *
2.95%
Yield 2026 * 3.28%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.42%
1 week-1.66%
Current month-1.66%
1 month+4.41%
3 months+9.22%
6 months-25.71%
Current year-1.66%
More quotes
1 week 1,180
Extreme 1180
1,225
1 month 1,165
Extreme 1165
1,255
Current year 1,180
Extreme 1180
1,240
1 year 985
Extreme 985
1,600
3 years 985
Extreme 985
2,360
5 years 985
Extreme 985
2,360
10 years 830
Extreme 830
2,360
More quotes
Manager TitleAgeSince
Chief Executive Officer 63 16/05/2024
Chief Tech/Sci/R&D Officer - -
Sales & Marketing 56 -
Director TitleAgeSince
Director/Board Member 61 01/01/2008
Chairman 61 16/05/2024
Director/Board Member 54 18/05/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.42%-1.66%-5.95%-41.91% 327.4Cr
+1.64%+3.79%+35.14%+201.01% 97TCr
+2.61%+2.65%+47.63%+20.53% 51TCr
-0.02%-0.06%+25.62%+44.55% 39TCr
-0.77%+4.64%+28.58%+17.88% 37TCr
-0.94%+4.80%+29.61%+22.52% 29TCr
-1.21%+1.63%+10.02%-2.31% 27TCr
-0.20%+4.85%+25.30%+35.24% 27TCr
+1.97%+11.51%-36.94%-15.37% 26TCr
-0.17%+1.50%+24.14%+20.16% 18TCr
Average +0.04%+3.12%+18.31%+30.23% 35.11TCr
Weighted average by Cap. +0.43%+3.71%+26.03%+69.45%
See all sector performances

Financials

2025 *2026 *
Net sales 34,88500Cr 206.59Cr 176.91Cr 164.52Cr 153.38Cr 286.59Cr 19TCr 307.39Cr 1.9TCr 744.95Cr 8.91TCr 774.77Cr 758.88Cr 33TCr 37,65300Cr 222.98Cr 190.94Cr 177.57Cr 165.55Cr 309.33Cr 20TCr 331.78Cr 2.05TCr 804.05Cr 9.61TCr 836.23Cr 819.08Cr 35TCr
Net income 3,56000Cr 21Cr 18Cr 17Cr 16Cr 29Cr 1.9TCr 31Cr 193.42Cr 76Cr 909.13Cr 79Cr 77Cr 3.33TCr 3,88500Cr 23Cr 20Cr 18Cr 17Cr 32Cr 2.07TCr 34Cr 211.04Cr 83Cr 991.96Cr 86Cr 85Cr 3.64TCr
Net Debt -5,16700Cr -31Cr -26Cr -24Cr -23Cr -42Cr -2.76TCr -46Cr -280.67Cr -110.33Cr -1.32TCr -114.74Cr -112.39Cr -4.84TCr -6,46300Cr -38Cr -33Cr -30Cr -28Cr -53Cr -3.45TCr -57Cr -351.09Cr -138.01Cr -1.65TCr -143.53Cr -140.59Cr -6.05TCr
More financial data * Estimated data
Logo PT Kalbe Farma Tbk.
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
Employees
12,784
More about the company
Date Price Change Volume
12/26/12 1,220.00 Rp +2.95% 6,08,42,500
09/26/09 1,185.00 Rp -0.42% 1,98,65,000
08/26/08 1,190.00 Rp -0.42% 4,01,94,800
07/26/07 1,195.00 Rp 0.00% 6,65,77,900
06/26/06 1,195.00 Rp -2.45% 5,61,39,100

End-of-day quote INDONESIA S.E., January 09, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
1,220.00IDR
Average target price
1,685.00IDR
Spread / Average Target
+38.11%
Consensus

Quarterly revenue - Rate of surprise